BioCentury
ARTICLE | Clinical News

Tracleer bosentan: Phase III ongoing

May 18, 2009 7:00 AM UTC

Actelion said an independent DSMB recommended continuation of the double-blind, placebo-controlled, international Phase III BUILD-3 trial evaluating 125 mg of Tracleer given twice daily in 616 patient...